The historical rank and industry rank for Bactiguard Holding AB's FCF Margin % or its related term are showing as below:
CHIX:BACTBs'
s FCF Margin % Range Over the Past 10 Years
Min: -29.87 Med: -3.41 Max: 26.79
Current: -1.63
During the past 13 years, the highest FCF Margin % of Bactiguard Holding AB was 26.79%. The lowest was -29.87%. And the median was -3.41%.
CHIX:BACTBs's FCF Margin % is ranked worse than 53.13% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs CHIX:BACTBs: -1.63
Bactiguard Holding AB FCF Margin % Related Terms
Bactiguard Holding AB FCF Margin % Historical Data
* Premium members only.
The historical data trend for Bactiguard Holding AB's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:BACTBS vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Bactiguard Holding AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bactiguard Holding AB FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Bactiguard Holding AB's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bactiguard Holding AB (CHIX:BACTBS) has a FCF Margin % of -19.52% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bactiguard Holding AB and its competitors. According to the industry distribution chart, Bactiguard Holding AB ranks #433 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 53.1%.
Is Bactiguard Holding AB's FCF Margin % too high?
Bactiguard Holding AB's current FCF Margin % is -19.52%. Based on the distribution chart, Bactiguard Holding AB ranks #433 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bactiguard Holding AB has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #433 out of 815 companies for FCF Margin %. This places Bactiguard Holding AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bactiguard Holding AB and its competitors. Bactiguard Holding AB's current FCF Margin % is -19.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current FCF Margin % of -19.52%. The stock's GF Value™ is kr264.39, compared to a current price of kr128.60 — trading 51.4% below its estimated fair value. The current FCF Margin % is -19.52%. Bactiguard Holding AB's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current FCF Margin % is -19.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of kr128.60 is trading 51.4% below its estimated GF Value™ of kr264.39.
Key valuation signals for CHIX:BACTBS:
FCF Margin %: -19.52%
GF Value™: kr264.39 vs. price of kr128.60 (51.4% below fair value)
No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
48GF Score
Get the complete analysis for CHIX:BACTBS
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BACTBS has been successfully added to your 
